Literature DB >> 18234661

Exacerbations in cystic fibrosis: 3--Management.

A Smyth1, J S Elborn.   

Abstract

Exacerbations of pulmonary symptoms in patients with cystic fibrosis must be recognised early and treated vigorously in order to maintain pulmonary function and relieve symptoms. The aetiology of these exacerbations is discussed, together with the options for treatment and the evidence to support treatment choices.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18234661     DOI： 10.1136/thx.2006.060905

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  18 in total

1.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Authors:  Edith T Zemanick; Brandie D Wagner; J Kirk Harris; Jeffery S Wagener; Frank J Accurso; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2010-06

Review 2.  Antibiotic and anti-inflammatory therapies for cystic fibrosis.

Authors:  James F Chmiel; Michael W Konstan; J Stuart Elborn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

3.  [Emergencies in adult mucoviscidosis patients].

Authors:  C Smaczny; T Born; T O F Wagner
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743

Review 4.  Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Edward Charbek
Journal:  Cochrane Database Syst Rev       Date:  2022-08-01

5.  Subjective and Objective Assessments of Flow-Volume Curve Configuration in Children and Young Adults.

Authors:  Daniel J Weiner; Erick Forno; Leanna Sullivan; Gabriel A Weiner; Geoffrey Kurland
Journal:  Ann Am Thorac Soc       Date:  2016-07

Review 6.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

7.  Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study.

Authors:  Alejandro A Pezzulo; David A Stoltz; Douglas B Hornick; Lakshmi Durairaj
Journal:  BMJ Open       Date:  2012-04-19       Impact factor: 2.692

Review 8.  Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment.

Authors:  Luiz Vicente Ribeiro Ferreira da Silva Filho; Flavia de Aguiar Ferreira; Francisco José Caldeira Reis; Murilo Carlos Amorim de Britto; Carlos Emilio Levy; Otavio Clark; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

9.  Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Edward Charbek
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30

10.  Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  Heidi Mulcahy; Laetitia Charron-Mazenod; Shawn Lewenza
Journal:  PLoS Pathog       Date:  2008-11-21       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.